Clinical trial
Bioequivalence Study of Clonazepam 2 Mg Tablets/immediate Release Tablets in Healthy Subjects in a Fasting Condition
NCT06834503 is registered in ClinicalTrials.gov with Centro de Atencion e Investigacion Medica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence Study of Clonazepam 2 Mg Tablets/immediate Release Tablets in Healthy Subjects in a Fasting Condition
- Lead sponsor
- Centro de Atencion e Investigacion Medica
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- June 10, 2025
- Completion date
- November 1, 2025
- Enrollment
- 24 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, healthy donors